Eagle Pharmaceuticals, Inc. Lessee, Operating Lease, Liability, to be Paid
Eagle Pharmaceuticals, Inc. had Lessee, Operating Lease, Liability, to be Paid of $2.37 million as of 2023-06-30, per its 10-Q/A filed 2023-08-09.
Discontinued › Notes › Commitment and Contingencies › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDue · last filed 2023-08-09
- 2023-06-30: Lessee, Operating Lease, Liability, to be Paid $2.37M.
- 2023-03-31: Lessee, Operating Lease, Liability, to be Paid $2.79M.
- 2022-12-31: Lessee, Operating Lease, Liability, to be Paid $3.21M.
- 2022-09-30: Lessee, Operating Lease, Liability, to be Paid $3.62M.
| Period end | Lessee, Operating Lease, Liability, to be Paid |
|---|---|
| 2023-06-30 | $2.37M 10-Q/A · filed 2023-08-09 |
| 2023-03-31 | $2.79M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $3.21M 10-K · filed 2023-03-23 |
| 2022-09-30 | $3.62M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $4.03M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $3.98M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $4.33M 10-K · filed 2022-03-08 |
| 2021-09-30 | $4.68M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $5.03M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $5.38M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $5.72M 10-K · filed 2021-03-05 |
| 2020-09-30 | $5.90M 10-Q · filed 2020-11-02 |
| 2020-06-30 | $6.24M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $6.58M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $6.61M 10-Q · filed 2020-11-02 |
| 2019-09-30 | $6.89M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $3.09M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $3.37M 10-Q · filed 2019-05-07 |